News from Investopedia

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Stocks Tariffs Investors Shares Stock Crypto Assets Cryptocurrency Stock Market Ethereum Price Markets Xrp Investment Stablecoin Blockchain Etf Bse Sec Eth Ipo Index Solana Trade Earnings Inflation Revenue Coinbase Interest Rates Token China Sensex Wall Street Nasdaq Federal Reserve Traders Treasury Gold Nse Bse Sensex Economy Usd Profit Digital Assets Tesla Nifty Sp 500 Indian Markets Sp Global Nao Macro Assets Derivative Gains Saleyard Borders Pdx Circle Payments Network Inu

Filter by:

Past 24 hours
Past week
Past month
Past year

ABC News Business
BBC Business
Business Insider Markets
CBC Business
City A.M.
CNBC Business
CoinDesk
Cointelegraph
Crypto News
CryptoSlate
Decrypt
Economic Times Markets
Euronews Business
Financial Post Top Stories
Financial Times
Finextra Crypto
Finextra Market
Finextra Wealth
Globe and Mail Investing
Investing.com Global Markets
Investing.com Global Mkts
Investopedia
Kiplinger
MarketWatch MarketPulse
MarketWatch Top Stories
Quartz
Sky News Money
Sydney Morning Herald Biz
Sydney Morning Herald Business
TechCrunch Fintech
The Block
The Guardian – Business
WSJ Markets News

Eczema × Past month × Investopedia ×

Investopedia • Jun 24, 2025

Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results

The substantial increase in Nektar Therapeutics' share price reflects investor optimism following successful clinical trial outcomes for a new eczema treatment.

Read Full Article →